Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

CD55 antibody (FITC)

The Mouse Monoclonal anti-CD55 antibody has been validated for FACS. It is suitable to detect CD55 in samples from Human.
Catalog No. ABIN1106468

Quick Overview for CD55 antibody (FITC) (ABIN1106468)

Target

See all CD55 Antibodies
CD55 (Complement Decay-Accelerating Factor (CD55))

Reactivity

  • 124
  • 31
  • 7
  • 4
  • 4
  • 4
  • 3
  • 2
  • 2
  • 2
Human

Host

  • 86
  • 64
  • 6
  • 5
  • 1
  • 1
  • 1
  • 1
Mouse

Clonality

  • 103
  • 60
  • 2
Monoclonal

Conjugate

  • 79
  • 18
  • 15
  • 10
  • 5
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This CD55 antibody is conjugated to FITC

Application

  • 93
  • 92
  • 40
  • 37
  • 35
  • 22
  • 17
  • 15
  • 14
  • 14
  • 14
  • 4
  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS)

Clone

2C6
  • Cross-Reactivity (Details)

    Species reactivity (tested):Human

    Purification

    Protein A agarose

    Immunogen

    Human adenocarcinoma cell line (PC3)

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    0.5 mg/mL

    Buffer

    PBS, 0.09 % NaN3, 1 % BSA

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store undiluted at 2-8 °C.
  • Target

    CD55 (Complement Decay-Accelerating Factor (CD55))

    Alternative Name

    CD55 / DAF

    Background

    CD55, also known as decay-accelerating factor (DAF), is a GPI-anchored membrane inhibitor of complement. It inhibits complement activation by interfering with the function of C3 and C5 convertases in both the classical and alternative pathways. CD55 is expressed on most cells to protect them from complement-mediated attack. CD55 and other membrane complement regulatory proteins (CD46 and CD59) are frequently overexpressed on cancer cells, possibly as a mechanism for cancer cells to overcome lysis by complement. Virus-receptor interactions have been elucidated for several viruses that use CD55 as an adhesion or invasion receptor, including enterovirus, echovirus, and coxsackie B virus. Moreover, CD55 also interacts with an epidermal growth factor-seven-span transmembrane (EGF-TM7) receptor, CD97. CD97 antigen becomes immediately up-regulated on most leukocytes during activation and is constitutively expressed by macrophages, dendritic cells, and some epithelial tumors.Synonyms: Complement decay-accelerating factor

    Gene ID

    9606

    UniProt

    P08174

    Pathways

    Complement System, Regulation of Leukocyte Mediated Immunity
You are here:
Chat with us!